For a link to the pdf of the press release please click here
To Register for the webcast or listen to the replay please follow the link below
AUSTIN, Texas, January 2, 2020 – Vermillion, Inc. (Nasdaq: VRML), a bioanalytical-based women’s health company focused on gynecologic disease, today announced that management will participate in two investor events in San Francisco during the week of January 13, 2020.
Vermillion President and Chief Executive Officer, Valerie Palmieri will present a corporate update at the 2020 Biotech Showcase on January 13 at 9:30 am PST. The presentation will be webcast and found on the investor relations section of Vermillion’s website.
In addition, CEO and Chief Financial Officer, Robert Beechey, will host institutional investor and partnering meetings at the LifeSci Advisors Corporate Access Event, taking place at the Sir Francis Drake Hotel, January 13-15, 2020.
Details of the Biotech Showcase presentation are as follows:
Date: Monday, January 13, 2020
Time: 9:30 a.m. (PST)
Track: Franciscan A (Ballroom Level)
Location: Hilton San Francisco Union Square
To schedule a meeting with the Vermillion management team at the LifeSci Corporate Access Event, please register online here or by email to acc[email protected].